Fujitsu
@Fujitsu_Global and research institute RIKEN
@riken_en announced AI drug discovery technology that was capable of predicting structural protein changes using generative AI and electron microscope images. This innovation follows the recent introduction of Japan's second quantum computer, aligning with global efforts to enhance practical technology applications.
Fujitsu plans to integrate the prediction technology into the Fujitsu AI Platform, available from October 10, 2023. By combining the computational power of a newly developed 64 qubit quantum computer with Fujitsu's 40 qubit quantum computer simulators, both companies aim to provide this hybrid platform to businesses and research institutions, particularly in sectors like finance and drug discovery.
The collaboration seeks to expedite joint research efforts across various fields, including materials, finance, and drug discovery. Fujitsu and RIKEN are also exploring generative AI solutions for
#healthcare, aiming to revolutionize drug discovery by significantly reducing development time and costs. This technology enables precise acquisition of protein conformations, leading to innovative drug design processes. By leveraging AI in analyzing protein-antibody complexes and predicting structural changes swiftly and accurately, the partnership aims to improve efficiency for doctors and offer potential life-changing treatments for patients. This initiative marks a significant step forward in the intersection of quantum computing and generative AI for revolutionary advancements in healthcare solutions.
#quantumcomputing #AI #drugdiscovery #healthcare #TechnologyMagazine
technologymagazine.com/ai-an…